جست‌وجوی استاد و پژوهشگر

Guillermo Adolfo Repetto Kuhnمشاهده پروفایل

استاد

• Toxicology
• Forensic Sciences
• Criminalistics
• +۳ مورد دیگر

Guillermo Adolfo Repetto Kuhn is a Professor at Pablo de Olavide University in Seville, Spain, where he works in the Department of Molecular Biology and Biochemical Engineering within the Health Science and Techniques domain. His primary research area is Toxicology, with specific focus on Forensic Sciences and Toxicology through the FORYTOXICOL Research Group. Dr. Repetto Kuhn holds significant leadership positions in the toxicology community: President of REMA (Spanish Network of Alternative Methods) Moderator of TOXICOL - Toxicology Forum Moderator of 3ERRES - Forum on Alternative Methods to Animal Experimentation Member of AETOX (Spanish Toxicology Society) Member of GTEMA (Group on Alternative Methods) His research spans multiple domains of toxicology, with particular emphasis on developing and promoting alternative testing methods to animal experimentation. Dr. Repetto Kuhn has created important resources like the Inventory of Spanish Institutions and Scientists Interested in Alternative Methods and co-authored "FUNDAMENTAL TOXICOLOGY, 4th Ed" (2009) with Manuel Repetto Jiménez. His work bridges forensic toxicology, environmental toxicology, and regulatory science, with significant contributions to understanding chemical risks and developing safer testing methodologies. Analysis of Dr. Repetto Kuhn's publication record reveals a strong focus on environmental toxicology (particularly regarding endocrine disruptors like BPA), alternative testing methods using biological models, and applications of toxicology to medical genetics and pharmacology. His work demonstrates consistent commitment to advancing toxicological science while promoting ethical research practices that reduce reliance on animal testing. Dr. Repetto Kuhn actively contributes to academic programs including the International Master in Toxicology (Academic Committee), Master's Degree in Criminology and Forensic Sciences, Bachelor's Degree in Criminology, and doctoral programs in Biotechnology, Biomedicine and Health Sciences at Pablo de Olavide University.

• Cancer Biology
• Preclinical Cancer Pharmacology
• Drug Resistance in Colorectal Cancer
• +۵ مورد دیگر

Dr. Steven Shnyder is a Senior Lecturer in Cancer Biology at the University of Bradford's School of Pharmacy & Medical Sciences within the Faculty of Life Sciences. With over 35 years of experience as a research scientist, including 30 years post-doctoral work and 24 years specifically in preclinical cancer pharmacology at Bradford, he has established himself as a leading expert in cancer drug development and testing. His research interests span several critical areas in oncology, with a particular focus on identifying mechanisms of drug resistance in colorectal cancer. Dr. Shnyder has developed expertise in characterizing reticuloplasmins as anticancer drug targets, pharmacology of vascular disrupting agents, development of 3Rs methodologies, exploitation of fluorescent properties of anti-cancer therapeutics, and evaluation of the drugability of the tumour cell glycocalyx. His work bridges the gap between basic science and clinical application, with several compounds his team has screened progressing to clinical trials. Analysis of Dr. Shnyder's publication record reveals a consistent focus on improving preclinical cancer models, understanding drug resistance mechanisms, and implementing ethical research practices through the 3Rs principle. His most recent work shows increasing emphasis on translational research approaches that connect laboratory findings with potential clinical applications, particularly in colorectal cancer treatment. 80+ peer-reviewed journal articles 4 book chapters on in vivo methodology Multiple conference publications Dr. Shnyder serves as a Home Office Project and Personal Licence holder, managing both in vivo and in vitro studies at the Institute of Cancer Therapeutics (ICT). He line-manages a Research Associate focused on in vivo studies and a Research Technician specializing in in vitro screening. His leadership extends to co-investigating project grants and studentships focused on improving preclinical cancer pharmacology methodology from a 3Rs standpoint. His research team includes Patricia Cooper (Experimental Officer), Gary Lawson (Research Technician), and Marcella Sini (YCR Programme Grant Postdoctoral Researcher), working collaboratively with colleagues including L Patterson, P Loadman, R Falconer, and K Pors.

Dania Moviaمشاهده پروفایل

استادیار

• Biomedical Engineering
• Toxicology
• Cancer Research
• +۵ مورد دیگر

Dr. Dania Movia is an Assistant Professor in Biomedical & Health Services at Maynooth University's Department of Biology, serving as Principal Investigator at the Kathleen Lonsdale Institute for Human Health Research. She also holds an Adjunct Assistant Professorship at Trinity College Dublin's Radiation Therapy Discipline. Her research focuses on advancing respiratory research and replacing animal testing through New Approach Methodologies (NAMs). Education: MSc in Chemistry and Pharmaceutical Technologies, University of Trieste (2007) PhD in Chemistry, Trinity College Dublin (2012) Special Purpose Certificate in Academic Practice, Trinity College Dublin (2018) Master of Arts (jure officii), Trinity College Dublin (2023) Research Interests: Dr. Movia advocates for sustainable biomedical research via animal-free technologies, particularly in lung cancer and toxicity studies. She leads Ireland's first wet-lab dedicated to animal-free respiratory research, the Humane Biomedical Research Group. Her work includes developing 3D tissue models and extracellular vesicle-based therapeutics. Over €23M in funding has supported her projects, including €2M as Principal Investigator. Publications & Awards: With over 50 peer-reviewed articles, she co-edited Cancer Cell Culture and serves as Associate Editor for Frontiers in Pharmacology . Notable awards include the 2025 Animal-Free Research UK Outstanding Scientist Award and inclusion in the 2021 Irish Hospital Professional News Top 100. Grants & Funding: Major funders include the Irish Research Council, Science Foundation Ireland, and the European Commission. Key projects include INSPIRE (€12.8M) for lung cancer therapies and 3Rs-focused initiatives. Labs & Teams: Leads the Humane Biomedical Research Group, which develops animal-free preclinical models and translational therapies. Collaborates internationally through COST Action CA21139 and scientific advisory roles with Animal-Free Research UK.

• Fish Physiology
• Muscle Biology
• Aquaculture
• +۳ مورد دیگر

Bianka Grunow is a Researcher at the Research Institute for Farm Animal Biology (FBN) , leading the Working Group Fish Growth Physiology . Her research focuses on fish skeletal muscle development, meat quality assessment, and in vitro test systems for aquaculture species. Investigates myogenesis across fish lineages Develops automated video analytics for aquaculture monitoring Establishes methods for fish flesh quality evaluation Studies climate change impacts through fish cell cultures Her collaborative projects include partnerships with the University Medicine Greifswald . While no scientific awards are explicitly listed, her extensive publication record highlights contributions to fish physiology, developmental biology, and sustainable aquaculture practices. Key methodologies involve transcriptomic analysis, 3D cell cultures, and comparative studies of wild vs. farmed species.

Melissa E. Murrayمشاهده پروفایل

استاد

• Neuropathology
• Neuroimaging
• Neurodegenerative Diseases
• +۱۲ مورد دیگر

Melissa E. Murray, Ph.D., is a Professor of Neuroscience at Mayo Clinic in Jacksonville, Florida, with joint appointments in the Department of Neuroscience and the Department of Laboratory Medicine and Pathology. She leads the Translational Neuropathology Laboratory, where her research focuses on understanding the heterogeneity of Alzheimer’s disease and related neurodegenerative disorders through integrated neuropathological, neuroimaging, and genetic approaches. Dr. Murray’s research interests include atypical Alzheimer’s disease, selective hippocampal vulnerability, dementia with Lewy bodies, tauopathies, TDP-43 proteinopathies, and the impact of cerebrovascular disease on cognitive decline. Her lab employs advanced digital pathology and neuroimaging techniques to quantify brain changes and identify biomarkers that improve diagnostic accuracy and track disease progression. Her recent research trends focus on molecular and clinicopathologic heterogeneity in Alzheimer’s disease, including gene expression changes in the hippocampus, ethnoracial differences in disease survival, and the interplay between age, sex, and neuroanatomical vulnerability. She has published extensively on neuropathologic subtypes of AD and the use of PET imaging to detect tau pathology. Dr. Murray has received numerous scientific honors, including: Investigator of the Year, Mayo Clinic Florida (2022) Highly Cited Researcher, Clarivate (2020) de Leon Prize in Neuroimaging, Alzheimer’s Association (2016) Franz Nissl Young Investigator Award (2014) 40 Under 40 Award, Jacksonville Business Journal (2014) She has served as Principal Investigator on multiple NIH and Alzheimer’s Association grants, including studies on tau pathology in young-onset Alzheimer’s disease and the molecular underpinnings of clinical heterogeneity in AD. Dr. Murray has also chaired the Atypical Alzheimer’s Disease and Associated Syndromes group for the Alzheimer’s Association (2016–2021). Her lab, the Translational Neuropathology Laboratory, is actively involved in mentoring researchers and advancing neuropathological methodologies to uncover the biological mechanisms behind variable disease expression.

• Biomedical Science
• Microbiology
• Bacteriophage Therapy
• +۳ مورد دیگر

Martin Khechara is a Senior Lecturer in Biomedical Science (Microbiology) at the University of Wolverhampton 's School of Biology, Chemistry and Forensic Science. With a background in molecular biology and proteomics from Defence Science Technology Laboratories (DSTL) in Salisbury, he transitioned to academia in 2008. Expertise: Biomedical Countermeasures, Bacteriophage Therapy, Science Communication Professional Memberships: Society for General Microbiology, British Science Association His research spans pedagogical innovation (flipped classrooms, theatre-based learning) and public engagement strategies. Recent publications focus on phage applications, microbiology education, and outreach effectiveness. Recognized for best poster award at IBMS Congress 2015.

Gail Daviesمشاهده پروفایل

استاد

• Human Geography
• Science and Technology Studies
• Animal Studies
• +۱۲ مورد دیگر

Professor Gail Davies is a leading scholar in human geography at the University of Exeter, where she holds the position of Professor of Human Geography and serves as Director of Research and Impact for Human Geography. Her work bridges human geography, science and technology studies, and animal studies, with a focus on the spatial, ethical, and social dimensions of biomedical research involving animals. Her research centers on the geographies of science and technology, human and animal health, and the ethics and practices of animal research. She has pioneered interdisciplinary approaches to understanding laboratory animal research, particularly through the lens of the 3Rs (replacement, reduction, refinement), patient involvement, and translational science. Her work emphasizes the relational and spatial complexities of scientific practice. Gail led the Wellcome Trust-funded 'Animal Research Nexus' programme (2017–2023), a major collaborative project involving researchers from Oxford, Nottingham, Manchester, and Southampton, which explored the changing constitution of science, health, and animal welfare. She is currently collaborating on the 'Resisting Bodies' project (2020–2024) with the University of Oslo, examining immune system politics across human and animal domains. She has also worked with artist Helen Scalway on the micespace project, creating experimental visualizations of the spaces occupied by laboratory mice. Her research has informed national and international policy, including contributions to the Swiss National Science Foundation’s 3Rs framework and leadership of the UK Harm-Benefit Analysis Review. She is affiliated with the Wellcome Centre for Cultures and Environments of Health and the Microbes and Society @Exeter network. Chair, UK Review of Harm-Benefit Analysis in the Use of Animals in Research Lead contributor to Enhancing the 3Rs for the Swiss National Science Foundation Gail Davies has played a significant role in shaping interdisciplinary research on animal research ethics and public engagement. She mentors early-career researchers and collaborates widely across institutions and disciplines. Her work integrates creative and critical methodologies, including artistic collaborations, to challenge conventional scientific narratives. She has no known grants listed beyond the named projects, but her leadership roles suggest active grant management and supervision. She is involved in the micespace project, a long-term artistic and geographical collaboration with Helen Scalway (2010–2020), which functions as a speculative 'anti-archive' of laboratory mouse spaces, exploring the messiness and complexity of biomedical research environments.

Katya Tsaiounمشاهده پروفایل

پژوهشگر

• evidence-based methodologies
• evidence-based toxicology
• translational research
• +۵ مورد دیگر

Katya Tsaioun, PhD, MS is an Assistant Scientist at Johns Hopkins University's Bloomberg School of Public Health, with primary departmental affiliation in Environmental Health and Engineering. She serves as Director of the Evidence-Based Toxicology Collaboration (EBTC) and is affiliated with the Center for Alternatives to Animal Testing (CAAT). Her work focuses on establishing evidence-based methodologies in translational research to inform regulatory decisions in environmental and public health. PhD in Human Nutrition Science from Tufts University Friedman School of Nutrition Science and Policy (1999) Post-doctoral training in neurochemistry at Harvard Medical School MS from Leningrad Institute of Technology (1987) Dr. Tsaioun's research is centered on evidence-based methodologies in toxicology, with expertise in translating scientific innovations into policies and technologies that improve public health. Her work spans systematic review methods, evidence-based toxicology, and the development of alternative testing approaches that reduce reliance on animal models. She has made significant contributions to the application of evidence-based methods in environmental health risk assessment and the development of frameworks for decision-making in regulatory contexts. Analysis of her recent publications reveals a strong focus on advancing evidence-based approaches in toxicology and environmental health. Her work consistently addresses the development and implementation of systematic review methodologies, evidence-to-decision frameworks, and alternative testing strategies. Key trends include the evolution of the GRADE framework for environmental health applications, the implementation of New Approach Methodologies (NAMs) in regulatory toxicology, and the advancement of systematic review practices in environmental health research. Dr. Tsaioun has extensive experience bridging academic research, industry applications, and regulatory science. Before joining Johns Hopkins, she spent nearly two decades in the pharmaceutical industry leading translational drug-discovery teams. She founded Apredica, a company that became a leader in commercializing de-risking technologies, which was later acquired by Cyprotex (now Evotec), where she served as CSO and Board member. She currently serves on advisory boards and review committees for numerous governmental, commercial, and non-profit organizations, contributing her expertise in evidence-based methodologies and translational research. As Director of the Evidence-Based Toxicology Collaboration, Dr. Tsaioun leads international multi-stakeholder efforts to establish evidence-based practices in translational research. Her work connects with various initiatives including the 3Rs principles (Replacement, Reduction, Refinement of animal testing), exposome research, and the development of alternative chemical testing strategies. She is actively involved in advancing the science of systematic reviews in toxicology and environmental health, with particular emphasis on improving the quality and applicability of evidence for regulatory decision-making.

Arti Ahluwaliaمشاهده پروفایل

استاد

• In-vitro models
• Biomaterials
• Tissue Engineering
• +۳ مورد دیگر

Arti Ahluwalia is Professor of Bioengineering at the University of Pisa's School of Engineering, affiliated with the Research Center 'E. Piaggio' and serving as Director of the Interuniversity Center for the Promotion of the 3Rs Principles in Teaching and Research (Centro 3R). With a multidisciplinary background spanning physics, instrumentation science, and bioengineering, her research integrates biomaterials, microfabrication, and computational modeling. Research focuses on human-based organ and system models using soft materials, cell derivatives, and intelligent bioreactor design. Current projects include: in-vitro models of metabolic disease/aging, nanotoxicology, advanced imaging, and open biomedical engineering education. Her work has produced commercialized multicompartment bioreactors through spin-off companies Kirkstall Ltd and IVTech srl. Recent publications demonstrate strong emphasis on open-source medical devices, 3Rs principles implementation, and computational platforms for nanotoxicology and cellular construct design. Key themes include regulatory frameworks for open-source medical technology, diagnostic tools for resource-limited settings, and ethical alternatives to animal testing. Teaching encompasses Biomechanics of Tissues, Micro & Nanobioscopy, and Design Principles for Bionics Engineering across undergraduate and graduate biomedical engineering programs.

Miriam Zemanovaمشاهده پروفایل

پژوهشگر

• Wildlife Welfare
• Research Ethics
• 3Rs Principles
• +۴ مورد دیگر

Miriam Zemanova is a Researcher in the Department of Geosciences at the University of Fribourg, affiliated with the Environmental Sciences and Humanities Institute and the Animalfree Research foundation. She holds a PhD in Ecology and Evolution from the University of Bern and completed postdoctoral fellowships at the University of Basel and University of Technology Sydney. Her work focuses on wildlife welfare, research ethics, and promoting the 3Rs principles (replacement, reduction, refinement) in wildlife research. She created the 3RsWildlife.info resource to guide ethical practices. Her educational background includes BSc in Applied Ecology (Czech University of Life Sciences), MSc in Ecological Conservation (Cranfield University), and MSc in Forestry, Water and Landscape Management (Czech University of Life Sciences). Research interests emphasize ethical methodologies, non-invasive genetic sampling, and compassionate conservation. Key publications address animal welfare in amphibians, university policies on animal replacement, and educational efficacy of humane teaching methods. She advocates for systemic reforms in wildlife research ethics and collaborates across disciplines to advance evidence-based conservation strategies. Her recent work includes analyzing attitudes toward animal dissection in Swiss education and assessing the prevalence of conscientious objection policies in veterinary training. Despite no listed awards, her contributions to ethical frameworks are influential in academic and applied conservation contexts. She maintains close ties with both academic and non-profit sectors through her dual affiliations.

• Costume design
• Design arts
• Rendering
• +۴ مورد دیگر

Szu-Feng Chen is an Associate Professor in the Department of Theatre and Dance at the University of New Hampshire. A globally recognized designer, she integrates unconventional materials through a 3R (recycle, reuse, reduce) framework while maintaining artistic excellence in visual storytelling. Education: B.F.A. in Set Design from Taipei National University of the Arts, M.F.A. in Design & Technology from the University of Texas at Austin Leadership: Director of Design and Theatre Technology at UNH Her research focuses on sustainable design practices and theatre technology innovation . With over a hundred theatrical productions across 20+ countries, her work has been showcased at prestigious events like World Stage Design (2022, 2009, 2005) and Prague Quadrennial (2023, 2007, 2003). Recent productions demonstrate her versatility in costume design and set construction for contemporary musicals, classical adaptations, and cross-cultural works. Notable themes include: Integration of ecological materials Textile recycling methodologies Digital rendering techniques Scientific awards include: Gold Sustainability Award (2021) Outstanding Assistant Professor Award (2014) at UNH Outstanding Alumnna of School of Theatre (2012) Active in professional organizations like USITT, OISTAT, and CAAFA, she contributes to advancing theatrical design while mentoring students in sustainable practices and technical innovation.

Frances Owenمشاهده پروفایل

استاد

• Human Rights
• Disability Studies
• Social Services Evaluation
• +۴ مورد دیگر

Frances Owen is a Professor in the Department of Child and Youth Studies at Brock University. Her work focuses on the intersection of organizational systems and clinical practice, with a particular emphasis on human rights advocacy for persons with intellectual and developmental disabilities. She collaborates extensively with community organizations to address deinstitutionalization, service delivery improvements, and cyber abuse prevention initiatives. Her research spans topics such as social service impact evaluation, interdisciplinary partnerships, and systemic organizational change. Dr. Owen’s research is characterized by its community-engaged approach, often involving participatory methodologies. She has contributed to policy development through projects like the Ontario Facilities Initiative studies, exploring outcomes of deinstitutionalization processes. Her work also emphasizes practical solutions, such as the Common Ground Co-operative case study, which evaluates social enterprise models supporting employment for individuals with disabilities. Her publications reflect a commitment to bridging academic inquiry with real-world impact, including co-editing volumes on human rights agendas and deinstitutionalization. Professional presentations highlight her advocacy for inclusive practices in mental health services and educational frameworks that empower marginalized groups. Dr. Owen’s expertise includes human rights education for individuals with disabilities, evidenced by projects like the 3Rs Health Knowledge Training Program. She has also pioneered comparative studies on training methodologies (e.g., computer-based vs. classroom learning) to enhance rights awareness among vulnerable populations.

Nathaniel Clarkمشاهده پروفایل

مدرس

• Toxicology
• Environmental Health
• Nanomaterials
• +۴ مورد دیگر

Nathaniel Clark is a Lecturer in Physiology affiliated with both the School of Health Professions and School of Biomedical Sciences at the University of Plymouth. His research focuses on the intersection of biology and chemistry in toxicology, particularly studying pollutants like micro/nanoplastics, nanomaterials, and their impacts on environmental and human health. He holds a dual role in teaching, leading modules in Nutritional Biochemistry and Physiology for Nutrition, Exercise, and Health students, alongside supervising undergraduate and postgraduate research projects. His research spans three core areas: (1) dietary toxicology of nanomaterials and nanoplastics in aquatic organisms, (2) plastic pollution's effects on human gut health and inflammatory diseases, and (3) trace element analysis in alternative diets. He has pioneered gold-standard methods using single particle ICP-MS and radioisotope tracing to study nanoplastics in fish tissues. His work emphasizes the 3R principles (replacement, reduction, refinement) in toxicology testing. Nathaniel supervises multiple PhD and MSc students investigating nanoplastic toxicity, gut health implications, and dietary alternatives. He collaborates widely, including roles as primary or secondary supervisor on studies involving fish bioaccumulation, IBD mechanisms, and metabolic health. His research aligns with UN Sustainable Development Goals (SDGs) targeting environmental sustainability and human health. Key facilities include access to state-of-the-art analytical tools for nanoparticle detection and in vitro/ex vivo biological testing models. He actively contributes to interdisciplinary efforts bridging toxicology, environmental science, and nutritional research.

Carrie Frieseمشاهده پروفایل

استاد

• Medical Sociology
• Science and Technology Studies
• Animal Studies
• +۷ مورد دیگر

Carrie Friese is a Professor in the Department of Sociology at the London School of Economics and Political Science (LSE), serving as Doctoral Programme Director. She specializes in Medical Sociology, Science and Technology Studies, and Animal Studies, with a focus on qualitative methodologies like Situational Analysis. Her research explores the intersections of human and non-human actors in biomedical settings, laboratory animal ethics, and the sociological implications of cloning and endangered species preservation. Dr. Friese has pioneered Situational Analysis alongside Adele Clarke and Rachel Washburn, emphasizing relational and mixed-methods approaches. Her educational background and career trajectory are not explicitly detailed in the text, but her extensive publications and research collaborations indicate advanced academic training in sociology and science studies. Key projects include a Wellcome Trust-funded study on laboratory animals and a Leverhulme Fellowship supporting her monograph on lab animal humanitarianism. Research interests include the ethics of care in translational medicine, the politics of invisibility in animal science, and the role of non-human actors in public health. Recent work involves co-leading an ESRC-funded project on mixed-methods data infrastructure for understanding social change impacts on individual lives. Friese teaches courses on the sociology of health, technology, and qualitative research methods. Her articles critically analyze topics like 'shadow bodies' of lab mice, the moral frameworks governing animal experimentation, and digital methods in situational analysis. She co-authored influential texts such as Situational Analysis: grounded theory after the interpretive turn and has contributed to debates on cloning, conservation ethics, and the future of endangered species. Though no specific awards are listed, her academic leadership roles and prolific publication record reflect significant scholarly recognition. Her work bridges sociology, science studies, and ethics, with implications for policy and practice in biomedical research and conservation biology.

Eva Bay Wedebyeمشاهده پروفایل

استاد پژوهشی

• Quantitative Structure-Activity Relationships (QSAR)
• Toxicology
• Regulatory Toxicology
• +۳ مورد دیگر

Eva Bay Wedebye is a Senior Executive Officer and Head of the Research Group for Chemical Risk Assessment and GMO at the National Food Institute (Technical University of Denmark). Her work focuses on (Q)SAR modeling for toxicity prediction, regulatory compliance (e.g., REACH), and reducing animal testing. She leads projects like PARC and FREIA, advancing tools for endocrine disruption assessment. Education: PhD in Environmental Chemistry (University of Copenhagen, 1997). She advises on OECD frameworks and contributes to the (Q)SAR Application Toolbox. Her research emphasizes large-scale chemical screening, including the Danish Advisory List for Self-Classification. Key research areas include QSAR model development/validation, chemical risk assessment, and FAIR data practices. Over 75 publications span QSAR applications in toxicity, endocrine disruption, and regulatory science. Recognition: 2016 Danish 3R-Center Prize for reducing animal testing. Active in conferences and policy initiatives, such as the RACEMiC roadmap for chemical mixture risk assessment. Labs/Teams: Directs the National Food Institute Research Group, collaborating internationally on projects like ATHENA (thyroid hormone disruption) and LIFE CONCERT REACH (in silico modeling networks).